Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.71
+0.14 (2.51%)
At close: May 12, 2025, 4:00 PM
5.84
+0.13 (2.28%)
After-hours: May 12, 2025, 6:47 PM EDT
Tenax Therapeutics Employees
As of December 31, 2024, Tenax Therapeutics had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,933,667
Market Cap
204.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TENX News
- 26 days ago - Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha
- 6 weeks ago - Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Tenax Therapeutics Announces $25 Million Private Placement - GlobeNewsWire
- 2 months ago - Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF - GlobeNewsWire
- 2 months ago - Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 6 months ago - Tenax Therapeutics, Inc. (TENX) Guggenheim Healthcare Innovation Conference (Transcript) - Seeking Alpha